Cash & equivalents increased 50.6%
Cash & equivalents changed +50.6% from the comparable as-filed period.
· Pharmaceutical Preparations
RESEARCH SNAPSHOTAnnexon, Inc.'s latest supported as-filed period reports net income of -$55.3M, 12.6% below the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed +50.6% from the comparable as-filed period.
Net income changed -12.6% from the comparable as-filed period.
Operating income changed -10.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
ANNX · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001614869-26-000004SEC ↗10-QAug 12, 2026Period Jun 30, 20260001193125-26-346779SEC ↗8-KAug 12, 2026Period Aug 12, 20260001193125-26-345672SEC ↗8-KAug 10, 2026Period Aug 10, 20260001193125-26-342524SEC ↗8-KAug 6, 2026Period Aug 6, 20260001193125-26-336867SEC ↗8-KJul 30, 2026Period Jul 30, 20260001193125-26-326199SEC ↗4Jun 15, 2026Period Jun 11, 20260001553338-26-000001SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Aug 10, 2026Filed Aug 12, 2026 | Blumenkranz Mark S.Director | Grant Or AwardDirect | 175,000 | $0 | $0 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Research & development changed +5.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Stock-based compensation changed +14.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001315797-26-000002